Market Analysis

A summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies, including key strategies and guidance...

In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies....

As noted in Part I of our quarterly revenue coverage, robotics and enabling technology in general continued to be a...

Several companies noted increased case volume in the third quarter, likely driven by a strong U.S. economy leading to more...

The 1H18 performance of companies that make up ~80% of the joint reconstruction market achieved 4.1% growth vs. 1H17. These...

The 21 companies we track collectively grew +3.6% in 1H18 vs. 1H17, still on pace to reach our estimates of...

Spine accounts for 18% of the orthopaedic industry's overall revenue. In 2017, sales of spine products (excluding biologics) exceeded $9...

Sales from arthroscopy/soft tissue products in 2017 surpassed $5.3 billion and grew 6.2% vs. 2016, according to our estimates published...

Alongside their 1Q18 results, numerous players reaffirmed or updated their full-year revenue guidance. Globus Medical increased its numbers based on...

Established orthopaedic players and startups alike seek to enter the trauma segment, and we think this dynamic will make trauma...